P42113 AF NFT

Asparagine synthetase [glutamine-hydrolyzing] 2

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeicxuicblhtyymqi4kwcny35gnlphxikpdo5mswudaizsyfinr5woy/metadata.json
IPFS of structure file: 
bafybeigjdj6jfpfrtgsd3ouz2umz6z45d3gdaogrxye6c2e2s26ml4dqzq/AF-P42113-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x6Ed09D80e98fE15DE51C9E7a8896AbF1f2365C3e
First NFT owner address (bech32): 
genesis1dmgfmq8f3ls4meguneag394t78ervhp7h90qf8
Current NFT ID #28811 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
28811
Accession (UniProt):
P42113
Name::
Asparagine synthetase [glutamine-hydrolyzing] 2
Experimental Method:
Predicted structure
Sequence source:
BACILLUS SUBTILIS (STRAIN 168)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P42113 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P42113|ASNH_BACSU Asparagine synthetase [glutamine-hydrolyzing] 2 OS=Bacillus subtilis (strain 168) OX=224308 GN=asnH PE=1 SV=2 MCGLAGIINLAAPRSQECTFHILKGMADAISYRGPDDEQYHIDSKVGFAFRRLSILDLVNGQQPFLNEDGSIVVMVNGEIYNYKELKASLHNHMFKTTSDCEVIVHLYEEKGIGFVDDIIGMFSIAIWDKNKNKVFLVRDRFGIKPLFYTELKHELIFASEIKSLFSHPHCPRQFNWKEALSDIWLSGEAASNHKETTSFFVNIQNLDAGHYLEINLTTNERKTASYWSLQDILLRQGYRENLHPDDLIEGYRELLADSVHRCLQSDVEVGLFLSGGIDSAAVAHFAAEKQDLHTFTVLSQSTFTNEDAKYAHWLAKDLHLPNHQVLYQLGNDELLQPESYKHLLWICETPFCGPEQLYKFHLHKYAKAIRPNLKVMLTGQGSDEFNGGYSTTLSPAENPSWEGFIESVNTMEMNRLHRLQGNIFRVWEEHFGLSPINLSYLKSNDSSQADPWQSYVLTKYRDLQMYNCWHEDRIAAANHIENRVPFLDHRLVEWVCGIPDGLRKDLLWDKSVLRKSLTNELHTSYTHRPKVPFFYGKDVRYTHKMMFHLLKKNNYQLIEEAFSHSDASSIIQVEHIHAIMTYLEDDPEFTNFEFLLRLVNMGLLSKMTKETPSVQLDITSHLESITIKDWHSQEGDIASRLNISANKCEGQDILALNPGVTLLRPESDSEHCIYIAEEGFIQFIVSEEDVGAWLHILCDINGKDTLHTILDRHGVSLEEVAKYIQEAIEHNIILIKQKNLPEGAYR